Fmr LLC Protalix Bio Therapeutics, Inc. Transaction History
Fmr LLC
- $1.52 Trillion
- Q2 2024
A detailed history of Fmr LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 6,791 shares of PLX stock, worth $7,809. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,791
Previous 2,526
168.84%
Holding current value
$7,809
Previous $3,000
133.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding PLX
# of Institutions
70Shares Held
5.61MCall Options Held
103KPut Options Held
4.6K-
Israel Englander Millennium Management LLC | New York, Ny811KShares$932,8330.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny805KShares$925,2890.0% of portfolio
-
Goldman Sachs Group Inc New York, NY462KShares$531,2510.0% of portfolio
-
Northern Trust Corp Chicago, IL423KShares$486,6940.0% of portfolio
-
Gsa Capital Partners LLP London, X0401KShares$461,4300.03% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $57.2M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...